Literature DB >> 26607043

Opioids in chronic obstructive pulmonary disease: the whole picture using all available evidence.

David C Currow1, Magnus Ekström1,2, Miriam J Johnson3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26607043      PMCID： PMC4799937          DOI： 10.1111/bcp.12842

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  10 in total

1.  Opioids in chronic obstructive pulmonary disease: the whole picture using all available evidence.

Authors:  David C Currow; Magnus Ekström; Miriam J Johnson
Journal:  Br J Clin Pharmacol       Date:  2016-01-04       Impact factor: 4.335

Review 2.  The management of chronic breathlessness in patients with advanced and terminal illness.

Authors:  Magnus P Ekström; Amy P Abernethy; David C Currow
Journal:  BMJ       Date:  2015-01-02

Review 3.  Effects of opioids on breathlessness and exercise capacity in chronic obstructive pulmonary disease. A systematic review.

Authors:  Magnus Ekström; Fredrik Nilsson; Amy A Abernethy; David C Currow
Journal:  Ann Am Thorac Soc       Date:  2015-07

4.  A comparison of symptom prevalence in far advanced cancer, AIDS, heart disease, chronic obstructive pulmonary disease and renal disease.

Authors:  Joao Paulo Solano; Barbara Gomes; Irene J Higginson
Journal:  J Pain Symptom Manage       Date:  2006-01       Impact factor: 3.612

5.  An international initiative to create a collaborative for pharmacovigilance in hospice and palliative care clinical practice.

Authors:  David C Currow; Debra Rowett; Matthew Doogue; Timothy H M To; Amy P Abernethy
Journal:  J Palliat Med       Date:  2012-02-21       Impact factor: 2.947

6.  Opioids for chronic refractory breathlessness: patient predictors of beneficial response.

Authors:  Miriam J Johnson; J Martin Bland; Stephen G Oxberry; Amy P Abernethy; David C Currow
Journal:  Eur Respir J       Date:  2012-12-20       Impact factor: 16.671

7.  A most stubborn bias: no adjustment method fully resolves confounding by indication in observational studies.

Authors:  Jaclyn L F Bosco; Rebecca A Silliman; Soe Soe Thwin; Ann M Geiger; Diana S M Buist; Marianne N Prout; Marianne Ulcickas Yood; Reina Haque; Feifei Wei; Timothy L Lash
Journal:  J Clin Epidemiol       Date:  2009-05-19       Impact factor: 6.437

8.  Benzodiazepine drug use and adverse respiratory outcomes among older adults with COPD.

Authors:  Nicholas T Vozoris; Hadas D Fischer; Xuesong Wang; Anne L Stephenson; Andrea S Gershon; Andrea Gruneir; Peter C Austin; Geoffrey M Anderson; Chaim M Bell; Sudeep S Gill; Paula A Rochon
Journal:  Eur Respir J       Date:  2014-04-17       Impact factor: 16.671

9.  Incident opioid drug use among older adults with chronic obstructive pulmonary disease: a population-based cohort study.

Authors:  Nicholas T Vozoris; Xuesong Wang; Hadas D Fischer; Andrea S Gershon; Chaim M Bell; Sudeep S Gill; Denis E O'Donnell; Peter C Austin; Anne L Stephenson; Paula A Rochon
Journal:  Br J Clin Pharmacol       Date:  2015-10-02       Impact factor: 4.335

10.  Safety of benzodiazepines and opioids in very severe respiratory disease: national prospective study.

Authors:  Magnus P Ekström; Anna Bornefalk-Hermansson; Amy P Abernethy; David C Currow
Journal:  BMJ       Date:  2014-01-30
  10 in total
  1 in total

1.  Opioids in chronic obstructive pulmonary disease: the whole picture using all available evidence.

Authors:  David C Currow; Magnus Ekström; Miriam J Johnson
Journal:  Br J Clin Pharmacol       Date:  2016-01-04       Impact factor: 4.335
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.